Directory Category: Drug Delivery
Vaccizone Selects Exothera for Process Development and GMP Manufacturing of its SARS CoV 2 Vaccine Based on Proprietary ASC Technology
Istanbul, Turkey, 6 July 2022: Life Science Newswire – Vaccizone,
a vaccine development company focusing on innovative antigen delivery
technology, selected Exothera S.A. to fast-track process development of
its SARS CoV 2 vaccine for European clinical trials.
European Medicines Agency Commences Review of Aripiprazole 2-Month Long-Acting Injectable for the Maintenance Treatment of Schizophrenia in Adult Patients Stabilised with Aripiprazole
LONDON, UK, 17 June 2022 – Otsuka Pharmaceutical Europe Ltd.
(‘Otsuka’) and H. Lundbeck A/S (‘Lundbeck’) today announce that the
European Medicines Agency (EMA) has accepted the Marketing Authorisation
Application (MAA) for aripiprazole as a 2-month ready-to-use (RTU)
long-acting injectable (LAI) for the maintenance treatment of
schizophrenia in adult patients stabilised with aripiprazole.
